2025 Review Confirms Long-Acting Reversible Contraception Reduces Adolescent Pregnancy Rates Most Effectively

An updated 2025 systematic review pooling data across multiple countries has reaffirmed that long-acting reversible contraception — specifically the contraceptive implant and intrauterine devices — produces significantly lower unintended pregnancy rates among adolescents and young women compared to short-acting methods such as the pill, primarily due to its independence from daily user adherence. Given that unintended adolescent pregnancy carries significant social, educational, and health implications, ensuring that the most effective contraceptive information reaches young women and their families — across every community in Dubai, from Jumeirah to Mankhool — remains an important public health priority that this research helps to reinforce with clear, current data.

What the Review Found
The 2025 analysis found failure rates for LARC methods among adolescents to be consistently below 1%, compared to failure rates of 5 to 9% for short-acting hormonal methods such as the combined pill when used under typical real-world conditions, where missed doses and inconsistent use are common, particularly among younger users.

Why This Distinction Matters Clinically
The dramatic difference between LARC and short-acting method failure rates in real-world use is driven almost entirely by user-dependent factors — LARC methods, once correctly placed, require no daily action, removing the most common source of contraceptive failure among adolescents and young adults specifically.

Addressing Outdated Concerns
This updated evidence continues to dismantle outdated clinical hesitancy around offering IUDs to adolescents and nulliparous young women, a historical concern not supported by current research. Modern, smaller-profile IUDs are specifically designed to be suitable for this population, and major bodies including ACOG now explicitly recommend LARC as a first-line option for adolescent contraception where appropriate.

What This Means for Families in Dubai
For families across Dubai navigating conversations about contraception for older adolescent daughters — whether for pregnancy prevention, menstrual symptom management, or both — this research supports an open, non-judgemental discussion of the full range of contraceptive options, including LARC methods, rather than defaulting only to short-acting options.

An Additional Clinical Benefit Worth Considering
This evidence also has implications beyond contraceptive effectiveness alone — LARC methods, particularly the hormonal IUS, frequently provide the additional benefit of significantly reduced menstrual bleeding and pain, addressing two clinical needs simultaneously for many adolescent patients who experience both contraceptive needs and troublesome periods. This dual benefit is often a meaningful consideration in family discussions about which method best fits a young patient’s overall needs, beyond pregnancy prevention alone.

How This Compares to Current Standard Practice in Dubai
Adolescent contraceptive counseling across Dubai increasingly reflects international guidance favouring LARC discussion alongside traditional options, supported by growing comfort among specialists in offering IUDs and implants to younger, nulliparous patients.